Radiotherapy Combined Chimeric Antigen Receptor T-Cells Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma(R/R DLBCL)

被引：0
|
作者：
Zhou, Lili [1 ]
Liu, Yifan [1 ]
Ye, Shiguang [1 ]
Li, Ping [1 ]
Li, Shaoguang [2 ]
Liang, Aibin [1 ]
机构：
[1] Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai, Peoples R China
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184352
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Prognostic differences of refractory/relapsed nodal and extranodal diffuse large B-cell lymphoma in the chimeric antigen receptor T cell therapy era
    Song, Zhiqiang
    Xu, Lili
    Tang, Gusheng
    Gao, Lei
    Wang, Libing
    Ni, Xiong
    Chen, Li
    Chen, Jie
    Wang, Tao
    Feng, Dongge
    Yu, Xuejun
    Yang, Jianmin
    Wang, Yang
    CLINICA CHIMICA ACTA, 2022, 532 : 72 - 78
  • [22] Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia
    Tan, Ya Hwee
    Yoon, Dok Hyun
    Davies, Andrew J.
    Buske, Christian
    Boo, Yang Liang
    Somasundaram, Nagavalli
    Lim, Francesca
    Ong, Shin Yeu
    Jeyasekharan, Anand
    Izutsu, Koji
    Kim, Won Seog
    Chan, Jason Yongsheng
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [23] A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Kalakonda, Nagesh
    Cavallo, Federica
    Follows, George
    Goy, Andre
    Vermaat, Joost S. P.
    Casasnovas, Olivier
    Lavee, Orly
    Maerevoet, Marie
    Zijlstra, Josee
    Bakhshi, Sameer
    Bouabdallah, Reda
    Choquet, Sylvain
    Gurion, Ronit
    Hill, Brian
    Jaeger, Ulrich
    Sancho, Juan-Manuel
    Schuster, Michael
    Thieblemont, Catherine
    De la Cruz, Fatima
    Egyed, Miklos
    Mishra, Sourav
    Offner, Fritz
    Vassilakopoulos, Theodoros
    Warzocha, Krzysztof
    McCarthy, Daniel
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita
    Shah, Jatin
    Van den Neste, Eric
    Canales, Miguel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S248 - S249
  • [24] Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
    Awasthi, Rakesh
    Tam, Constantine S.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Foley, Stephen Ronan
    Van Besien, Koen
    Wagner-Johnston, Nina D.
    Kersten, Marie Jose
    Schuster, Stephen J.
    Salles, Gilles Andre
    Maziarz, Richard Thomas
    Anak, Oezlem
    Pacaud, Lida Bubuteishvili
    Gazi, Lucien
    Waldron, Edward
    Hamilton, Jason
    Pruteanu, Iulian
    Tai, Feng
    Mueller, Karen Thudium
    Waller, Edmund K.
    BLOOD, 2017, 130
  • [25] Magrolimab in Combination with Rituximab plus Chemotherapy in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Maakaron, Joseph
    Asch, Adam S.
    Popplewell, Leslie L.
    Collins, Graham P.
    Flinn, Ian W.
    Ghosh, Nilanjan
    Keane, Colin
    Ku, Matthew
    Mehta, Amitkumar
    Roschewski, Mark
    O'Hear, Carol
    Ren, Xuehan
    Villa, Bertha
    Lal, Indu
    Smith, Sonali M.
    Advani, Ranjana H.
    BLOOD, 2022, 140 : 3728 - 3730
  • [26] Real-World Sequential Use of CD19-Directed Therapies for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab Preceding Chimeric Antigen Receptor T- Cell (CAR-T) Therapy
    Epperla, Narendranath
    Nastoupil, Loretta J.
    Feinberg, Bruce
    Pathak, Prathamesh
    Amoloja, Theresa
    Gentile, Danielle
    Saverno, Kim
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S477 - S477
  • [27] Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphoma
    Houot, Roch
    Armand, Philippe
    Jacobson, Caron A.
    EUROPEAN JOURNAL OF CANCER, 2020, 131 : 51 - 52
  • [28] Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden
    Qu, Changju
    Ping, Nana
    Kang, Liqing
    Liu, Hailing
    Qin, Songbin
    Wu, Qian
    Chen, Xiaochen
    Zhou, Meng
    Xia, Fan
    Ye, Aihua
    Kong, Danqing
    Li, Caixia
    Yu, Lei
    Wu, Depei
    Jin, Zhengming
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (01) : 32 - 37
  • [29] MYC plus relapsed and refractory (R/R) diffuse large b-cell lymphoma (DLBCL): Impact of additional hits and outcomes with subsequent therapy.
    Epperla, Narendranath
    Maddocks, Kami J.
    Salhab, Mohamed
    Chavez, Julio C.
    Reddy, Nishitha M.
    Karmali, Reem
    Umyarova, Elvira
    Bachanova, Veronika
    Glenn, Martha Jane
    Xavier, Ana Carolina
    Zhou, Zheng
    Hernandez-Ilizaliturri, Francisco J.
    Barta, Stefan K.
    Lansigan, Frederick
    Mehta, Amitkumar N.
    Flowers, Christopher
    Cohen, Jonathon Brett
    Fenske, Timothy S.
    Hamadani, Mehdi
    Costa, Luciano J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
    Hoffmann, Marc S.
    Hunter, Bradley D.
    Cobb, Patrick W.
    Varela, Juan C.
    Munoz, Javier
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (07): : 440 - 448
12345